Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine.
The stress protein hsp27 is constitutively expressed in several human cells and shows a rapid phosphorylation following treatment with tumor necrosis factor-alpha (TNF-alpha). hsp27 usually displays native molecular mass ranging from 100 to 700 kDa. Here, we have analyzed the TNF-alpha-mediated changes in the phosphorylation, cellular localization, and structural organization of hsp27 in HeLa cells. We report that the TNF-alpha-mediated hsp27 phosphorylation is a long-lasting phenomenon that correlates with the cytostatic effect of this cytokine. Following TNF-alpha treatment, the rapid phosphorylation of hsp27 occurred concomitantly with complex changes in the intracellular distribution and structural organization of this protein. This resulted in the quantitative redistribution of hsp27 toward the soluble phase of the cytoplasm. In addition, during the first 2 h of TNF-alpha treatment, a transient increase in the native molecular mass of most hsp27 molecules (< or = 700 kDa) occurred. Then, by 4 h of TNF-alpha treatment, the native size of this stress protein drastically regressed (< 200 kDa). During this phenomenon, the phosphorylated isoforms of hsp27 remained concentrated in the small or medium-sized oligomers (< 300 kDa) of this protein. We also analyzed the properties of human hsp27 in transfected murine L929 cell lines that constitutively express this protein. In these cells, TNF-alpha induced modifications in the phosphorylation, intracellular distribution, and oligomerization of human hsp27 similar to those observed in HeLa cells. Moreover, the expression of hsp27 in L929 cells was found to correlate with a reduced cytotoxicity of this cytokine. Hence, the complex changes in the phosphorylation, intracellular locale and structural organization of human hsp27 may be related to the protective activity of this protein against the deleterious effects induced by TNF-alpha.
Mehlen
P
P
Laboratoire du Stress Cellulaire, CNRS UMR-106, Université Claude Bernard, LYON-I, Villeurbanne, France.
Mehlen
A
A
Guillet
D
D
Preville
X
X
Arrigo
A P
AP
D000818:Animals; D004351:Drug Resistance; D006367:HeLa Cells; D006360:Heat-Shock Proteins / Q000737:chemistry*; D006801:Humans; D046911:Macromolecular Substances; D051379:Mice; D010766:Phosphorylation; D014162:Transfection; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D006360:Heat-Shock Proteins; D046911:Macromolecular Substances; D014409:Tumor Necrosis Factor-alpha